How Much Potassium Iodide Should You Take for Radiation?

The standard adult dose of potassium iodide (KI) for radiation protection is 130 mg, taken as a single tablet when authorities issue an advisory during a nuclear emergency. That dose floods the thyroid gland with stable iodine so it cannot absorb the radioactive form, and when taken just before or at the time of exposure, it blocks upward of 95 percent of the radioactive iodine dose to the thyroid. But the number on the tablet is only part of the story. Timing, age, pregnancy status, and the type of radiation involved all change whether KI will actually help you, and the gap between “ideal” and “too late” is surprisingly narrow.

Why the Thyroid Is the Target

In a nuclear accident or detonation, one of the most dangerous byproducts released into the environment is radioactive iodine, primarily iodine-131. The thyroid gland actively collects iodine from the bloodstream to manufacture hormones, so it acts like a sponge for whatever iodine circulates through the body. If radioactive iodine gets inhaled or swallowed, the thyroid concentrates it in a small space, delivering a focused radiation dose that can eventually cause thyroid cancer or other thyroid disease. Children are especially vulnerable because their thyroid glands are smaller and more active.

Potassium iodide works by pre-loading the thyroid with ordinary, non-radioactive iodine. Once the gland is saturated, it essentially stops taking in more iodine for a period of roughly 24 hours. Any radioactive iodine that enters the body during that window passes through and gets excreted without accumulating. The concept is simple: fill the parking lot before the dangerous cars arrive.

Doses by Age Group

The dose is not one-size-fits-all. Younger people have smaller thyroid glands that saturate with less iodine, and giving them a full adult dose risks unnecessary side effects. The FDA and the World Health Organization both publish age-based guidelines, and while the exact cutoffs differ slightly between agencies, the doses are broadly consistent:

Adults and adolescents over 68 kg (about 150 lb): 130 mg
Children ages 3 to 12: 65 mg
Infants ages 1 month to 3 years: 32 mg (roughly a quarter of a 130 mg tablet, or as a liquid formulation)
Newborns under 1 month: 16 mg
Pregnant or breastfeeding women: 130 mg (the standard adult dose, but with important caveats discussed below)

These doses refer specifically to potassium iodide, not elemental iodine. A 130 mg KI tablet contains about 100 mg of iodide, because some of the weight comes from the potassium. Research on adults with normal thyroid function has shown that ingesting 100 mg of iodide just before radioactive iodine exposure blocks at least 95 percent of the thyroid radiation dose.¹ Earlier research using doses of 100 to 200 mg found even higher blocking, reducing irradiation by more than 98 percent when taken before exposure.²

Liquid formulations are available for infants and young children who cannot swallow tablets. Some emergency stockpiles include scored tablets that can be halved or quartered and dissolved in juice or formula. Getting the dose right matters, but in a genuine emergency, approximate dosing is far better than no dosing at all.

Timing Changes Everything

If there is one thing to remember about potassium iodide, it is that when you take it matters at least as much as whether you take it. The ideal window is in the hours just before exposure, or as close to the moment of exposure as possible. Pre-exposure dosing reduces thyroid irradiation by more than 98 percent.² But the protective effect drops quickly once radioactive iodine has already entered the body.

When KI is administered within about two hours after radioactive iodine intake, it still provides meaningful protection, blocking roughly 75 to 79 percent of the thyroid dose depending on the isotope involved.³ By three hours after exposure, the same dose still cuts uptake by about half, which is worthwhile but dramatically less effective than taking it on time.² After six to eight hours, there is little benefit left. The thyroid has already grabbed most of the radioactive iodine it is going to absorb, and the stable iodine arrives too late to compete.

This steep drop-off is why emergency planners emphasize rapid distribution. Having a supply in your home, especially if you live near a nuclear power plant, eliminates the delay of waiting for a public distribution point to open. The protective window is measured in hours, not days.

How Long to Keep Taking It

A single 130 mg dose saturates the adult thyroid for roughly 24 hours. If radioactive iodine is still present in the environment the next day, a second dose may be recommended. In most scenarios public health authorities will issue daily guidance on whether to redose, because repeated high-iodine intake carries its own risks, particularly for the thyroid.

Extended use beyond a few days is generally discouraged unless authorities explicitly advise it. The concern is that prolonged iodine excess can itself disrupt thyroid function, causing either overactivity or underactivity. For most nuclear incidents, radioactive iodine in the air peaks in the first few days and then drops off, so the dosing window is usually short. Evacuation and food-supply controls take over as the primary protective measures once the initial plume has passed.

Pregnant Women, Newborns, and Older Adults

Pregnancy complicates the picture in both directions. On one hand, the developing fetus begins producing its own thyroid hormones around the 12th week of gestation, making it vulnerable to radioactive iodine from that point on. On the other hand, excess stable iodine can suppress fetal thyroid function and potentially cause goiter. Current guidance recommends that pregnant women take the standard 130 mg dose in a radiation emergency, but advises follow-up with fetal ultrasound surveillance through the remainder of the pregnancy and monitoring of the newborn’s thyroid function afterward.⁴ Breastfeeding women should also take the adult dose and ensure that their infant receives the age-appropriate infant dose separately, since breast milk alone may not deliver enough KI fast enough.

Newborns are the most sensitive group. Their thyroid glands are tiny, highly active, and less able to handle an iodine surplus. The recommended neonatal dose is just 16 mg, and even at that level, thyroid monitoring after administration is prudent.⁵ Excessive iodine exposure during pregnancy or lactation has been linked to cases of thyroiditis, goiter, and hypothyroidism in newborns.⁶ The takeaway for parents is straightforward: give the correct small dose, not a fragment of your own tablet eyeballed in the kitchen, and seek medical follow-up as soon as the emergency permits.

Adults over 40 present a different calculation. Their risk of radiation-induced thyroid cancer is considerably lower than for children or younger adults, because thyroid cancer from radiation exposure typically takes decades to develop, and the thyroid becomes less susceptible with age. At the same time, older adults are more likely to have underlying thyroid conditions, such as nodular goiter or subclinical hyperthyroidism, that make them more prone to side effects from a large iodine dose. For this reason, several countries recommend that adults over 40 take KI only if projected thyroid doses are very high, essentially only in the most severe scenarios.

The “Iodine Allergy” Question

People often ask whether they should skip KI if they are “allergic to iodine.” The reality is that true allergy to iodide ions is extraordinarily rare. Much of the confusion stems from three unrelated medical situations that have been lumped together under the “iodine allergy” umbrella, and research has systematically dismantled each connection.

A reaction to radiocontrast dye, the kind used in CT scans, is not evidence of KI allergy. Contrast reactions are typically triggered by the contrast medium’s chemical structure and osmolality, not by the iodine atoms within it. Allergic contact dermatitis from iodine-containing antiseptics like povidone-iodine is a skin-level reaction that does not indicate the kind of immune response that would make swallowing a KI tablet dangerous. And perhaps the most persistent myth: a seafood allergy has nothing to do with iodine. Shellfish allergies are driven by specific proteins in the shellfish, not by the trace iodine present in the animal.⁷

What you should actually check is whether you are allergic to any of the inactive ingredients in a particular KI formulation, such as binders, fillers, or dyes. If you have a confirmed history of a severe reaction specifically to potassium iodide itself, that is a legitimate contraindication, but it is vanishingly uncommon. For the vast majority of people, including those who have been told they are “iodine allergic,” KI is safe in an emergency.

What We Learned From Poland After Chernobyl

The largest real-world test of mass KI distribution happened in Poland in 1986, in the days following the Chernobyl disaster. Polish health authorities made the rapid decision to distribute potassium iodide across the population, and roughly 16 million people received single doses. Side effects were rare, and the campaign achieved an estimated 40 percent reduction in projected thyroid radiation dose.⁸

That 40 percent figure is lower than the 95-plus percent blocking seen in controlled settings, and the gap is instructive. In the Polish experience, many people received their dose hours after initial exposure rather than before it. Distribution logistics, communication delays, and the chaotic nature of the emergency all meant that timing was far from ideal. The experience confirmed two things simultaneously: KI is safe enough for mass distribution without individual medical supervision, and its effectiveness depends heavily on how quickly it reaches people. The lesson shaped emergency planning worldwide, shifting the focus toward predistribution to households near nuclear facilities rather than relying on post-event distribution alone.

Predistribution and Shelf Life

Several countries and some U.S. states have adopted predistribution programs, providing KI tablets in advance to households within a defined radius of nuclear power plants. Tennessee was an early adopter of this approach in the United States, distributing tablets to homes near its nuclear facilities.⁹ The logic is simple: if the tablets are already in your medicine cabinet, you do not lose critical hours waiting for a distribution point to open.

A common concern with keeping KI on hand is whether the tablets expire. Potassium iodide is a stable inorganic salt, and when stored properly in a sealed container away from heat and moisture, it retains its potency for years beyond the printed expiration date. The FDA and the Department of Defense operate a Shelf-Life Extension Program that tests stockpiled pharmaceuticals, including KI, and has repeatedly confirmed that products meeting quality standards remain effective well past their original expiration dates.¹⁰ In practical terms, a sealed packet of KI tablets stored in a cool, dry place is likely still good many years later. If you bought tablets during a scare and then forgot about them, they are probably fine.

What KI Cannot Do

Potassium iodide protects one organ against one type of radioactive contamination. It saturates the thyroid against radioactive iodine, and that is all it does. It offers zero protection against external radiation from a nuclear blast, gamma rays from fallout on the ground, or internal contamination with other radionuclides like cesium-137 or strontium-90. In a nuclear emergency, multiple radioactive materials are typically released at once, and KI addresses only one piece of the puzzle.

For cesium-137 contamination, a different agent is used: Prussian blue, an insoluble iron compound that binds cesium and thallium ions in the gastrointestinal tract, preventing absorption and promoting excretion. Researchers have explored using Prussian blue and potassium iodide together to cover both cesium and iodine contamination simultaneously.¹¹ Prussian blue is FDA-approved for cesium and thallium decorporation, but unlike KI it is not widely predistributed to the public and would typically be administered under medical direction after confirmed exposure.

The broader point is that KI should not create a false sense of comprehensive protection. Sheltering in place, sealing windows and doors, avoiding contaminated food and water, and evacuating when instructed are all at least as important as taking a pill. KI is one tool in a larger emergency response, not a radiation shield.

Dietary Supplements Are Not the Same Thing

During periods of nuclear anxiety, some people stockpile iodine dietary supplements and assume they are equivalent to pharmaceutical-grade KI tablets. They are not. Dietary supplements containing iodine, such as kelp capsules or liquid iodine drops, are manufactured under different standards. The FDA does not regulate ingredient standards for dietary supplements the way it does for pharmaceutical products, meaning the actual iodine content in a supplement can vary considerably from what the label claims.¹²

Even if a supplement did contain its labeled amount, the doses in typical dietary products are measured in micrograms, not milligrams. A standard daily iodine supplement might contain 150 micrograms, which is about a thousand times less than the 130 milligram emergency dose. You would need to swallow an absurd number of capsules to approximate the thyroid-blocking dose, and doing so would deliver unpredictable amounts of iodine along with whatever other ingredients the supplement contains. In an emergency, use pharmaceutical KI tablets specifically manufactured for thyroid blocking. If you do not have them, contact your local emergency management agency rather than improvising with supplements.

When Authorities Say to Take It

You should not take KI preemptively based on news reports or social media speculation. The decision to recommend KI is made by public health officials based on projected thyroid radiation doses, and the threshold varies by age group and country. Generally, guidelines suggest that the benefits of KI outweigh the risks of adverse effects for populations vulnerable to radioiodine exposure.¹³ In the United States, state and local authorities working with the Nuclear Regulatory Commission make the call. In European countries, national radiation protection agencies issue the order.

Taking KI when there is no actual radioactive iodine in your environment accomplishes nothing protective and exposes you to the small but real risk of thyroid side effects. The 2022 surge in KI purchases across Europe, driven by fears related to the conflict in Ukraine, illustrated this dynamic. Millions of tablets were bought by people hundreds or thousands of miles from any plausible exposure zone. For most of those buyers, the tablets were unnecessary, and some people who took them preemptively experienced thyroid disruption they did not need to risk. The correct approach is to keep a supply on hand if you live in a plausible exposure zone, know the dose for each family member, and wait for official instructions before taking it.